Accustem Sciences (ACUT) Other Working Capital Changes (2023)

Accustem Sciences (ACUT) posted quarterly Other Working Capital Changes of -$29603.0 for Q1 2023.

Accustem Sciences (ACUT) Other Working Capital Changes (2023) Analysis & Trends

Accustem Sciences (ACUT) has reported Other Working Capital Changes for 1 consecutive years, with -$29603.0 the latest figure, recorded in Q1 2023.

In Q1 2023, Other Working Capital Changes changed N/A year-over-year to -$29603.0; the TTM figure through Dec 2023 stood at -$29603.0 (changed N/A YoY), while the FY2023 annual figure was -$29603.0, down 200.0% from the prior year.
Other Working Capital Changes was little changed at -$29603.0 in Q1 2023 per ACUT's latest filing.
Across five years, Other Working Capital Changes topped out at -$29603.0 in Q1 2023 and bottomed at -$29603.0 in Q1 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	Accustem Sciences	2.57 Mn	2.56 Mn	-

Download Data